Evidence map›Paper›PMID 32031264›Full record

ArticleJournal of medical virology2020

Evolving status of the 2019 novel coronavirus infection: Proposal of conventional serologic assays for disease diagnosis and infection monitoring.

Shu-Yuan Xiao, Yingjie Wu, Huan Liu

Abstract readComment
In one paragraph

Article in Journal of medical virology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Guidelines: Anaesthesia in the context of COVID-19 pandemic.Anaesthesia, critical care & pain medicine · 2020
    Guideline
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2023
    Review
  18. Article
  19. Article
  20. Risk management and communication plans from SARS to COVID-19 and beyond.The International journal of health planning and management · 2022
    Review

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Shu-Yuan XiaoDepartment of Pathology, Wuhan University Zhongnan Hospital, Wuhan University Center for Pathology and Molecular Diagnostics, Wuhan, China.ORCID 0000-0003-0484-932X
Yingjie WuDepartment of Pathology, Wuhan University Zhongnan Hospital, Wuhan University Center for Pathology and Molecular Diagnostics, Wuhan, China.
Huan LiuDepartment of Pathology, Wuhan University Zhongnan Hospital, Wuhan University Center for Pathology and Molecular Diagnostics, Wuhan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ChiropteraCoronavirusPneumoniaAnimalsBetacoronavirusClinical Laboratory TechniquesCoronavirus InfectionsCOVID-19 TestingDisease OutbreaksSARS-CoV-2

Identifiers

PMID32031264
PMCPMC7167054

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.